OPTH · Optimi Health Corp.
Market Cap
$28.20M
Shares
5.73M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.91
Open$4.88
Day$4.72–4.98
Available close range$4.01–6.08
Avg vol 30d24K
Short int18K · 0.3% float · 1.0d
Short vol16%
DataMay 2026–Aug 2026
The closing range uses available history since May 20, 2026; less than a full year is stored.
Up next
FQ4-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+4%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
43%
mid-range
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.31% of float · ▼ -14.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
10 holders — 13F breadth
Squeeze score
36
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
97%
annualized · 1-yr
Max drawdown
−34%
past year
ATR
5.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+4%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
43%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+10 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.31% of float · ▼ -14.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
10 holders — 13F breadth
Price context
position in its available closing range
Range low $4
Now $5 · 43%
Range high $6
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OPTH
this stock
Optimi Health Corp.
|
$28.20M | — | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$57.58B | +15.3% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.38B | -0.1% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.46B | -0.8% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OPTH | -1.4% | +1.2% | — | +1.2% | — |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -1.9% | +0.0% | — | -1.4% | — |
Key facts
CIK
2027329
CUSIP
68405H308
13F (30d)
10 filings
10 filers
Visit website
Investor relations